VALSARTAN HYDROCHLOROTHIAZIDE EVOLUGEN 160 mg/25 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400922141886
  • CIP7 2214188
  • CIS 63075856

What the source publishes

Holder
EVOLUPHARM
Active ingredients
HYDROCHLOROTHIAZIDE, VALSARTAN
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2012-03-09
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400922141886
{
  "cis": "63075856",
  "cip7": "2214188",
  "form": "comprimé pelliculé",
  "name": "VALSARTAN HYDROCHLOROTHIAZIDE EVOLUGEN 160 mg/25 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)",
  "cip13": "3400922141886",
  "holder": "EVOLUPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "EVOLUPHARM"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "13.29",
  "authorisedOn": "2012-03-09",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "25 mg",
      "linkageNumber": "2",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "VALSARTAN",
      "nature": "SA",
      "strength": "160 mg",
      "linkageNumber": "1",
      "substanceCode": "15734",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "10.53",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "VALSARTAN HYDROCHLOROTHIAZIDE EVOLUGEN 160 mg/25 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2022-12-09",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "VALSARTAN"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400922141886"